What is the address of DOKTER BERNARD RAPPE?

The registered office of DOKTER BERNARD RAPPE is located at Coupure 365, 9000 Gent.

Is DOKTER BERNARD RAPPE still active?

Yes. According to the CBE (29 September 2026) DOKTER BERNARD RAPPE is active, legal situation “Normale toestand”, started on 26 December 2003.

Is DOKTER BERNARD RAPPE registered on Peppol?

Yes, DOKTER BERNARD RAPPE is registered on the Peppol network with ID 0208:0862413835.

What is the enterprise number of DOKTER BERNARD RAPPE?

The enterprise number of DOKTER BERNARD RAPPE is BE0862413835.

When was DOKTER BERNARD RAPPE founded?

DOKTER BERNARD RAPPE was founded on 26 December 2003.

Who are the directors of DOKTER BERNARD RAPPE?

According to the 2025 annual accounts, the directors of DOKTER BERNARD RAPPE are: Bernard Rappe, Gerda Okerman.

Is DOKTER BERNARD RAPPE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 December 2003; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DOKTER BERNARD RAPPE make in 2025?

DOKTER BERNARD RAPPE posted a profit after taxes of € 173,749 in financial year 2025.

What is the revenue of DOKTER BERNARD RAPPE?

As a small company, DOKTER BERNARD RAPPE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 307,340.

DOKTER BERNARD RAPPE (Private Limited) - Gent

Dossier DOKTER BERNARD RAPPE, printed on 29 September 2026 from databakkes.be/en/0862413835/dokter-bernard-rappe. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER BERNARD RAPPE from Gent, company number BE0862413835, closed financial year 2025 with a result of € 173,749 after tax. For that financial year DOKTER BERNARD RAPPE recorded a gross margin of € 307,340 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 213,197 to € 173,749. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Growing

€ 1.3 million

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 173,749

▼ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 347,647

▲ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 154,828 paid out

89 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 33,219

▼ 48% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 39,645

▲ € 33,753 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 19,840

▼ 20% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 400,399 Gross margin 2022: € 400,399 First fiscal year in the series	€ 344,000 Gross margin 2023: € 344,000 ▼ 14% vs 2022 (€ 400,399) Unfavourable step	€ 354,351 Gross margin 2024: € 354,351 ▲ 3% vs 2023 (€ 344,000) Favourable step	€ 307,340 Gross margin 2025: € 307,340 ▼ 13% vs 2024 (€ 354,351) Unfavourable step	▼ 13%
Profit after taxes	€ 249,345 Profit after taxes 2022: € 249,345 First fiscal year in the series	€ 202,427 Profit after taxes 2023: € 202,427 ▼ 19% vs 2022 (€ 249,345) Unfavourable step	€ 213,197 Profit after taxes 2024: € 213,197 ▲ 5% vs 2023 (€ 202,427) Favourable step	€ 173,749 Profit after taxes 2025: € 173,749 ▼ 19% vs 2024 (€ 213,197) Unfavourable step	▼ 19%
Equity	€ 1,060,452 Equity 2022: € 1,060,452 First fiscal year in the series	€ 1,153,444 Equity 2023: € 1,153,444 ▲ 9% vs 2022 (€ 1,060,452) Favourable step	€ 1,263,917 Equity 2024: € 1,263,917 ▲ 10% vs 2023 (€ 1,153,444) Favourable step	€ 1,282,619 Equity 2025: € 1,282,619 ▲ 1% vs 2024 (€ 1,263,917) Favourable step	▲ 1%
Total debts	€ 130,031 Total debts 2022: € 130,031 First fiscal year in the series	€ 80,295 Total debts 2023: € 80,295 ▼ 38% vs 2022 (€ 130,031) Favourable step	€ 112,528 Total debts 2024: € 112,528 ▲ 40% vs 2023 (€ 80,295) Unfavourable step	€ 134,762 Total debts 2025: € 134,762 ▲ 20% vs 2024 (€ 112,528) Unfavourable step	▲ 20%
Cash	€ 264,563 Cash 2022: € 264,563 First fiscal year in the series	€ 325,379 Cash 2023: € 325,379 ▲ 23% vs 2022 (€ 264,563) Favourable step	€ 335,757 Cash 2024: € 335,757 ▲ 3% vs 2023 (€ 325,379) Favourable step	€ 347,647 Cash 2025: € 347,647 ▲ 4% vs 2024 (€ 335,757) Favourable step	▲ 4%
Land & buildings	€ 10,239 Land & buildings 2022: € 10,239 First fiscal year in the series	€ 11,433 Land & buildings 2023: € 11,433 ▲ 12% vs 2022 (€ 10,239) Unchanged	€ 9,081 Land & buildings 2024: € 9,081 ▼ 21% vs 2023 (€ 11,433) Unchanged	€ 6,729 Land & buildings 2025: € 6,729 ▼ 26% vs 2024 (€ 9,081) Unchanged	▼ 26%
Retained profit	€ 1,040,368 Retained profit 2022: € 1,040,368 First fiscal year in the series	€ 1,133,579 Retained profit 2023: € 1,133,579 ▲ 9% vs 2022 (€ 1,040,368) Favourable step	€ 1,244,271 Retained profit 2024: € 1,244,271 ▲ 10% vs 2023 (€ 1,133,579) Favourable step	€ 1,263,193 Retained profit 2025: € 1,263,193 ▲ 2% vs 2024 (€ 1,244,271) Favourable step	▲ 2%
Dividend	€ 118,445 Dividend 2022: € 118,445 First fiscal year in the series	€ 109,216 Dividend 2023: € 109,216 ▼ 8% vs 2022 (€ 118,445) Unchanged	€ 102,505 Dividend 2024: € 102,505 ▼ 6% vs 2023 (€ 109,216) Unchanged	€ 154,828 Dividend 2025: € 154,828 ▲ 51% vs 2024 (€ 102,505) Unchanged	▲ 51%
Balance sheet total	€ 1,190,483 Balance sheet total 2022: € 1,190,483 First fiscal year in the series	€ 1,233,739 Balance sheet total 2023: € 1,233,739 ▲ 4% vs 2022 (€ 1,190,483) Unchanged	€ 1,376,445 Balance sheet total 2024: € 1,376,445 ▲ 12% vs 2023 (€ 1,233,739) Unchanged	€ 1,417,381 Balance sheet total 2025: € 1,417,381 ▲ 3% vs 2024 (€ 1,376,445) Unchanged	▲ 3%

Key figures of DOKTER BERNARD RAPPE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER BERNARD RAPPE?

What happened at DOKTER BERNARD RAPPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: profit of € 173,749 (▼ 19% vs 2024). Source: NBB ↗
Dec 26, 2003 Start of the company according to the CBE. KBO
Dec 22, 2003 New establishment in Gent. KBO

In short

From € 249,345 profit in 2022 to € 173,749 profit in 2025.

Paid € 389,694 in corporate taxes since 2022.

Best year ever: 2022, with € 249,345 profit.

Paid out € 484,994 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER BERNARD RAPPE? We notify you, reason included.

Follow DOKTER BERNARD RAPPE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Bernard Rappe

Gerda Okerman

DOKTER BERNARD RAPPE

Aalst Urology Group 9.1%

Behind DOKTER BERNARD RAPPE are Bernard Rappe and Gerda Okerman. It owns 9.1% of Aalst Urology Group itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Bernard Rappe

Director

Gerda Okerman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Coupure 365

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0862.413.835
VAT number: BE 0862.413.835
Registered office: Coupure 365, 9000 Gent
Names & denominations: DOKTER BERNARD RAPPE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 December 2003
Peppol: Active · Active since 9 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗